Cinctive Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-194,386
Closed -$1.46M 314
2024
Q4
$1.46M Sell
194,386
-79,573
-29% -$598K 0.07% 243
2024
Q3
$2.08M Buy
+273,959
New +$2.08M 0.11% 217